URGN - UroGen Pharma Ltd
IEX Last Trade
13.92
-0.080 -0.575%
Share volume: 924,667
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$14.00
-0.08
-0.57%
Summary score
15%
Profitability
8%
Dept financing
2%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.98%
Return on assets
-13.9%
Return on sales
-4501.78%
Return on invested capital
83.41%
Total debt ratio
7.95%
Debt ratio change over timeo
-0.92%
Current Ratio
13.61%
Quick Ratio
14.79%
Cash Position Ratio
10.62%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.81%
Return on assets
-18.22%
Return on sales
-8548.39%
Return on invested capital
-122.86%
Total debt ratio
9.8%
Debt ratio change over timeo
-1.14%
Current Ratio
8.87%
Quick Ratio
7.84%
Cash Position Ratio
2.89%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-21.97%
Return on assets
-19.74%
Return on sales
-8548.39%
Return on invested capital
-213.1%
Total debt ratio
11.43%
Debt ratio change over time
-1.09%
Current Ratio
7.91%
Quick Ratio
7.84%
Cash Position Ratio
2.29%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-111.38%
Return on assets
-110.45%
Return on sales
-7293.01%
Return on invested capital
198.3%
Total debt ratio
-91.89%
Debt ratio change over time
-0.92%
Current Ratio
11.83%
Quick Ratio
33.35%
Cash Position Ratio
8.1%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | URGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.98% | -3.05% | 11.55% | 6.27% |
| Return on assets | -13.9% | 3.6% | 3.57% | 5.27% |
| Return on sales | -4501.78% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 83.41% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 38% | 69% | 62% |
| Total debt ratio | 7.95% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.92% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 8.87% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 7.84% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.89% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 7% | 14% | 15% |
| Short-term ratios | URGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.81% | -25.62% | 17.94% | 7.14% |
| Return on assets | -18.22% | 3.26% | 3.67% | 4.71% |
| Return on sales | -8548.39% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -122.86% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 9.8% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.14% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 8.87% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 7.84% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.89% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 25% | 18% | 32% |